Drug intelligence / Profile preview

Bushen Huayu

Development stage: Unknown
Lead developer: Shanghai Sixth People’s Hospital
Modality: Small Molecules
Administration: Oral

Overview

Bushen Huayu is a Traditional Chinese Medicine (TCM) formulation used in integrative medicine protocols, specifically developed or utilized by the Shanghai 6th People's Hospital. The name refers to the TCM therapeutic principles of "Bushen" (tonifying the kidney) and "Huayu" (resolving blood stasis). It is primarily investigated for the treatment of cerebral small vessel disease (CSVD), where it is intended to stabilize blood pressure variability and mitigate related vascular risks. The formula typically consists of a combination of various herbs aimed at improving microcirculation and cognitive function in patients with age-related or vascular-driven neurological decline.

Other names: Bushen Huayu DecoctionBushen Huayu GranulesBushen Huayu Formula补肾化瘀

Beyond the preview

Go deeper on Bushen Huayu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bushen Huayu.

Explore the full profile